LINCOLN
Invest with MTF
Invest Now
Invest in Lincoln Pharmaceuticals with 3.01X leverage
Performance
- Low
- ₹527
- High
- ₹537
- 52 Week Low
- ₹490
- 52 Week High
- ₹980
- Open Price₹532
- Previous Close₹526
- Volume27,670
Investment Returns
- Over 1 Month + 1.5%
- Over 3 Month -1.81%
- Over 6 Month -11.11%
- Over 1 Year -13.62%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 13.3
- PEG Ratio
- -0.8
- Market Cap Cr
- 1,067
- P/B Ratio
- 1.6
- Average True Range
- 13.36
- EPS
- 39.94
- Dividend Yield
- 0.3
- MACD Signal
- -3.25
- RSI
- 53.41
- MFI
- 32.44
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹532.85
+
7.15
(1.36%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹526.31
- 50 Day
- ₹533.16
- 100 Day
- ₹545.59
- 200 Day
- ₹570.74
Resistance and Support
532.33
- R3 547.82
- R2 542.48
- R1 537.67
- S1 527.52
- S2 522.18
- S3 517.37
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Lincoln Pharmaceuticals F&O
About Lincoln Pharmaceuticals
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Similar Stocks to Lincoln Pharmaceuticals
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹532 As on 17 November, 2025 | 21:36
The Market Cap of Lincoln Pharmaceuticals is ₹1067.3 Cr As on 17 November, 2025 | 21:36
The P/E ratio of Lincoln Pharmaceuticals is 13.3 As on 17 November, 2025 | 21:36
The PB ratio of Lincoln Pharmaceuticals is 1.6 As on 17 November, 2025 | 21:36
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.